Endocrinology, Vol 130, 2284-2290, Copyright © 1992 by Endocrine Society

ARTICLES

A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes

S Okada, WY Chen, P Wiehl, B Kelder, HM Goodman, S Guller, M Sonenberg and JJ Kopchick
Department of Zoological and Biomedical Sciences, Ohio University, Athens 45701.

The effect of amino acid substitutions introduced to the third alpha- helix in bovine GH (bGH) was investigated. A GH analog (bGH-M8), in which three amino acids were substituted to form an idealized amphiphilic alpha-helix, possessed the same specific binding affinity as wild-type bGH to cell membranes prepared from 3T3-F442A cells or rat adipocytes. However, bGH-M8 failed to stimulate preadipocyte differentiation, as measured by the level of glycerol-3-phosphate dehydrogenase activity. An equimolar concentration of bGH-M8 was inhibitory for this adipogenic effect caused by bGH at a concentration of 30 pM. bGH-M8 also failed to induce an insulin-like response and reduced lipolytic potency in rat primary adipocytes. A 10-fold excess of bGH-M8 abolished the effect of wild-type bGH in the insulin-like and lipolytic assays. Thus, bGH-M8 inhibited these actions of wild-type bGH and, therefore, appears to be a competitive antagonist. These results suggest that a major biologically active domain resides in the third alpha-helix of bGH, which is independent of amino acids important in the initial interaction of GH with its receptor.

This article has been cited by other articles:

				A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely Growth Hormone Receptor Antagonists J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1503 - 1511. [Full Text] [PDF]

				K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span Endocrinology, September 1, 2003; 144(9): 3799 - 3810. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, M. Bidlingmaier, S. M. Anderson, W. S. Evans, Z. Wu, and C. J. Strasburger Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5737 - 5745. [Abstract] [Full Text] [PDF]

				J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF]

				S. J. Frank Minireview: Receptor Dimerization in GH and Erythropoietin Action--It Takes Two to Tango, But How? Endocrinology, January 1, 2002; 143(1): 2 - 10. [Abstract] [Full Text] [PDF]

				P. J. Trainer, W. M. Drake, L. A. Perry, N. F. Taylor, G. M. Besser, and J. P. Monson Modulation of Cortisol Metabolism by the Growth Hormone Receptor Antagonist Pegvisomant in Patients with Acromegaly J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2989 - 2992. [Abstract] [Full Text] [PDF]

				W. Y. Chen, P. Ramamoorthy, N.-y. Chen, R. Sticca, and T. E. Wagner A Human Prolactin Antagonist, hPRL-G129R, Inhibits Breast Cancer Cell Proliferation through Induction of Apoptosis Clin. Cancer Res., November 1, 1999; 5(11): 3583 - 3593. [Abstract] [Full Text] [PDF]

				N.-y. Chen, W. Y. Chen, and J. J. Kopchick Liver and Kidney Growth Hormone (GH) Receptors Are Regulated Differently in Diabetic GH and GH Antagonist Transgenic Mice Endocrinology, May 1, 1997; 138(5): 1988 - 1994. [Abstract] [Full Text] [PDF]

				M. Mellado, J. M. Rodriguez-Frade, L. Kremer, C. von Kobbe, A. M. de Ana, I. Merida, and C. Martinez-A Conformational Changes Required in the Human Growth Hormone Receptor for Growth Hormone Signaling J. Biol. Chem., April 4, 1997; 272(14): 9189 - 9196. [Abstract] [Full Text] [PDF]

				P. A. Harding, X. Wang, S. Okada, W. Y. Chen, W. Wan, and J. J. Kopchick Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization J. Biol. Chem., March 22, 1996; 271(12): 6708 - 6712. [Abstract] [Full Text] [PDF]

				X. Wang, S. C. Souza, B. Kelder, J. A. Cioffi, and J. J. Kopchick A 40-Amino Acid Segment of the Growth Hormone Receptor Cytoplasmic Domain Is Essential for GH-induced Tyrosine-phosphorylated Cytosolic Proteins J. Biol. Chem., March 17, 1995; 270(11): 6261 - 6266. [Abstract] [Full Text] [PDF]